AIML Innovations Establishes Medical Advisory Board to Advance AI-Driven ECG Solutions

AI/ML Innovations Inc. (AIML) has formed a Medical Advisory Board comprised of top cardiovascular experts. This board will guide clinical studies, regulatory strategies, and the adoption of AIML's AI-driven ECG processing solutions, MaxYield™ and CardioYield™, in both wearables and cardiology workflows. AIML also launched a redesigned website aimed at investors and stakeholders.

The advisory board includes prominent figures such as Dr. Paul Dorian from the University of Toronto, Dr. Alan Rabinowitz and Dr. Brett Heilbron from the University of British Columbia, and others. These members will enhance AIML's product development by integrating clinical insights into commercialization strategies. Peter Kendall, serving as Chair, will bridge clinical guidance and product execution.

AIML CEO Paul Duffy affirmed the company's dedication to leveraging AI in cardiac diagnostics, aiming for innovative solutions in AI-enhanced health technology.